AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
11.77
+0.29 (2.53%)
Dec 20, 2024, 4:00 PM EST - Market closed
AVITA Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 60.04 | 50.14 | 34.42 | 33.03 | 29.23 | 14.26 | Upgrade
|
| Revenue Growth (YoY) | 32.24% | 45.68% | 4.23% | 12.98% | 104.95% | 160.56% | Upgrade
|
| Cost of Revenue | 8.61 | 7.78 | 6.04 | 6.1 | 5.95 | 2.97 | Upgrade
|
| Gross Profit | 51.43 | 42.36 | 28.38 | 26.92 | 23.28 | 11.29 | Upgrade
|
| Selling, General & Admin | 88.04 | 65.54 | 45.24 | 37.92 | 37.06 | 48.73 | Upgrade
|
| Research & Development | 22.28 | 20.82 | 13.86 | 15.67 | 14.82 | 9.16 | Upgrade
|
| Other Operating Expenses | -0.06 | -1.43 | -3.22 | -1.59 | -2.06 | -3.93 | Upgrade
|
| Operating Expenses | 110.25 | 84.93 | 55.89 | 52 | 49.82 | 53.97 | Upgrade
|
| Operating Income | -58.82 | -42.57 | -27.51 | -25.08 | -26.54 | -42.68 | Upgrade
|
| Interest Expense | -5.19 | -1.14 | -0.02 | -0.03 | -0.02 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 9.42 | 8.48 | 0.89 | 0.05 | 0.02 | 0.69 | Upgrade
|
| EBT Excluding Unusual Items | -54.59 | -35.23 | -26.63 | -25.06 | -26.55 | -42.03 | Upgrade
|
| Asset Writedown | -0.09 | -0.09 | - | -0.04 | - | - | Upgrade
|
| Pretax Income | -57.27 | -35.32 | -26.63 | -25.1 | -26.55 | -42.03 | Upgrade
|
| Income Tax Expense | 0.05 | 0.07 | 0.04 | 0.04 | 0.04 | 0 | Upgrade
|
| Earnings From Continuing Operations | -57.32 | -35.38 | -26.67 | -25.14 | -26.58 | -42.03 | Upgrade
|
| Net Income | -57.32 | -35.38 | -26.67 | -25.14 | -26.58 | -42.03 | Upgrade
|
| Net Income to Common | -57.32 | -35.38 | -26.67 | -25.14 | -26.58 | -42.03 | Upgrade
|
| Shares Outstanding (Basic) | 26 | 25 | 25 | 24 | 23 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 25 | 25 | 24 | 23 | 20 | Upgrade
|
| Shares Change (YoY) | 1.92% | 1.32% | 2.64% | 7.42% | 11.75% | 26.31% | Upgrade
|
| EPS (Basic) | -2.23 | -1.40 | -1.07 | -1.03 | -1.17 | -2.07 | Upgrade
|
| EPS (Diluted) | -2.23 | -1.40 | -1.07 | -1.03 | -1.17 | -2.07 | Upgrade
|
| Free Cash Flow | -59.58 | -39.39 | -19.54 | -18.52 | -26.8 | -23.34 | Upgrade
|
| Free Cash Flow Per Share | -2.32 | -1.56 | -0.78 | -0.76 | -1.18 | -1.15 | Upgrade
|
| Gross Margin | 85.66% | 84.48% | 82.45% | 81.52% | 79.65% | 79.16% | Upgrade
|
| Operating Margin | -97.97% | -84.89% | -79.91% | -75.93% | -90.79% | -299.23% | Upgrade
|
| Profit Margin | -95.47% | -70.56% | -77.47% | -76.13% | -90.94% | -294.68% | Upgrade
|
| Free Cash Flow Margin | -99.23% | -78.56% | -56.77% | -56.09% | -91.66% | -163.62% | Upgrade
|
| EBITDA | -57.92 | -41.94 | -26.94 | -24.4 | -25.83 | -42.21 | Upgrade
|
| EBITDA Margin | -96.47% | -83.63% | -78.26% | -73.89% | -88.34% | -295.97% | Upgrade
|
| D&A For EBITDA | 0.9 | 0.63 | 0.57 | 0.67 | 0.72 | 0.47 | Upgrade
|
| EBIT | -58.82 | -42.57 | -27.51 | -25.08 | -26.54 | -42.68 | Upgrade
|
| EBIT Margin | -97.97% | -84.89% | -79.91% | -75.93% | -90.79% | -299.23% | Upgrade
|
| Advertising Expenses | - | 0.4 | 0.22 | - | 0.07 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.